SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept

Acta Dermato-Venereologica

Volumn 90, Issue 5, 2010, Pages 531-532

  Vilar Alejo, Jaime ^a   Dehesa, Luis ^a   De La Rosa del Rey, Pilar ^a   Novoa Medina, Javier ^a   Almazán, Pedro Valerón ^a   Medina, Néstor Santana ^a   Bastida, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CYCLOSPORIN; ETANERCEPT; ISOTRETINOIN; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE;

ACNE CONGLOBATA; ADULT; CASE REPORT; CHILL; CHRONIC HEPATITIS; DISTRESS SYNDROME; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUSTULE; PYODERMA; PYODERMA VEGETANS; SAPHO SYNDROME; SCAR; SCORING SYSTEM; SKIN BIOPSY; SKIN MANIFESTATION; SUPPURATIVE HIDRADENITIS; SYNOVITIS; TREATMENT DURATION;

ACQUIRED HYPEROSTOSIS SYNDROME; ANTI-INFLAMMATORY AGENTS; FOLLICULITIS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PYODERMA; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN; TREATMENT OUTCOME;

EID: 77957665500     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0895     Document Type: Letter

References (15)

1. Su WPD, Duncan SC, Perry HO. Blastomycosis-like pyoderma. Arch Dermatol 1979; 115: 170-173.
2. Schilling F. SAPHO syndrome. Orphanet encyclopedia, October 2004. Available from: http:/www.orpha.net/data/patho/GB/uk-SAPHO.pdf.
3. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice. What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
4. Carrera C, Mascaró JM, Moreno-Romero JA, Iranzo P, Palou J, Zamora E, et al. Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept. Dermatology 2007; 214: 77-81. (Pubitemid 46033005)
5. Schnetter D, Haneke E. Pyoderma gangraenosum vegetans. Hautartz 1994; 45: 635-638.
6. Yamasaki O, Iwatsuki K, Kaneko F. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet's disease. Adv Exp Med Biol 2003; 528: 339-341.
7. Govoni M, Colina M, Massara A, Trotta F. SAPHO syndrome and infections. Autoimmun Rev 2009; 8: 256-259.
8. Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, Grootenboer-Mignot S, Ruimy R, Meyer O, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology 2008; 47: 1160-1167. (Pubitemid 352038220)
9. Assmann G, Kuek O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009; 11: 140.
10. Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome: a follow-up of fourteen cases and review of the literature. Clin Exp Rheumatol 2009; 27: 112-115.
11. Ichikawa J, Sato E, Haro H, Ando T, Maekawa S, Hamada Y. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int 2009; 29: 713-715.
12. Moll C, Hernández MV, Cañete JD, Gómez-Puerta JA, Soriano A, Collado A, et al. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum 2008; 37: 299-306. (Pubitemid 351389483)
13. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complains, but may exacerbate cutaneous manifestations. Rheumatology 2006; 45: 730-733.
14. Van den Eynde M, Lecluyse K, Chioccioli C, Brouckaert M, Caussin E, Lammens P. Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature. Gastroenterol Clin Biol 2007; 31: 607-610. (Pubitemid 47094600)
15. Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, et al. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. Rheumatol 2008; 35: 1944-1949.